Intestinal immune cell populations

Intestinal immune cell populations represent a complex and highly specialized network of leukocytes located within the gut-associated lymphoid tissue (GALT), the lamina propria, and the intestinal epithelium (Mowat & Agace, 2014, Nature Reviews Immunology). These populations, including T cells, B cells, macrophages, and dendritic cells, are essential for maintaining mucosal homeostasis by balancing tolerance toward commensal microbes and dietary antigens with robust defense against pathogens (Belkaid & Hand, 2014, Cell). In pathological states such as inflammatory bowel disease (IBD), these populations become dysregulated, leading to an influx of pro-inflammatory cells and the excessive production of cytokines like TNF-alpha and IL-23 (Neurath, 2014, Nature Reviews Immunology). While not a single molecular target, these cell populations are the primary site of action for numerous biologics and small molecules, such as Vedolizumab, which prevents lymphocyte homing by targeting the alpha4beta7 integrin (Feagan et al., 2013, NEJM). Monitoring these populations through biomarkers like fecal calprotectin or endoscopic biopsy is critical for assessing treatment efficacy and disease progression (Walsh et al., 2016, Alimentary Pharmacology & Therapeutics). Consequently, modulating the composition and activity of these intestinal immune cells remains a cornerstone of modern gastroenterological therapy.

Other names

Gut-associated lymphoid tissueGALTIntestinal immune systemMucosal immune cellsLamina propria lymphocytesIntraepithelial lymphocytes

Therapeutic agents modulate these populations by inhibiting leukocyte trafficking to the gut mucosa, neutralizing pro-inflammatory cytokines, or inhibiting intracellular signaling pathways like the JAK-STAT pathway to restore immune homeostasis.